PUBLISHED DATE : Nov 2019 | Pages : 287
Fill out your details & get your free sample
Bioactive Wound Care Market Size, Share, Trends, Analysis Report by Products (Antimicrobial Dressings, Wound Care Biologics, Hydrocolloid Dressings, Alginate Dressings, and Collagen Dressings), Wound Type (Acute and Chronic), End-Users (Hospitals and Specialty Care Clinics, Long-Term Care Facilities, Home Healthcare, and Others), and Geography (North America, APAC, Europe, Latin America, and Middle East & Africa), Industry Analysis Report, Regional Outlook, Growth Trends, Competitive Landscape, Share & Forecast, 2019–2024
287 Pages
77 Tables
145 Charts
5 Regions
19 Countries
36 Companies
4 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (REVENUE) | USD 5.5 Billion (2024) |
| CAGR | 6% (2019-2024) |
| Base Year | 2018 |
| Historic Year | 2017 |
| Forecast Year | 2019 - 2024 |
| Market Segments | Products (Antimicrobial Dressings, Wound Care Biologics, Hydrocolloid Dressings, Alginate Dressings, and Collagen Dressings), Wound Type (Acute and Chronic), End-Users (Hospitals and Specialty Care Clinics, Long-Term Care Facilities, Home Healthcare, and Others) |
| Geographic Analysis | North America, APAC, Europe, Latin America, and Middle East & Africa |
| Countries Covered | US, Canada, Japan, China, India, South Korea, Australia, Germany, France, UK, Spain, Italy, Brazil, Mexico, Argentine, Turkey, Saudi Arabia ,South Africa, and Iran |
The introduction of smart bioactive wound dressing is likely to bring enormous business opportunities to the vendors in the market.
The global bioactive wound care market size to cross USD 5.5 billion by 2024, growing at a CAGR of over 6% during the forecast period. The increasing demand for innovative, effective, and proficient wound care products from surgeons as well as patients is expected to promote the market. With the availability of positive clinical evidences, demonstrating the superiority of newly launched advanced products, end-users are expected to adopt them as an alternative to other conventional products increasingly.
The growing incidence of chronic infection, including pressure ulcers, diabetic foot ulcers, venous ulcers as well as injuries related to burn, trauma, accidents, and surgery, is likely to increase the demand for innovative products. Favorable patient demographics is further driving manufacturers continue to launch new products. Another factor promoting development is their improved healing capacity and better clinical outcomes. In terms of geography, North America is leading, followed by Europe, APAC, Latin America, and MEA. The high growth of North America region can be attributed to the growing patient population suffering from acute and chronic infections due to the rise in lifestyle-related diseases such as diabetes.
The introduction of smart bioactive dressing is likely to bring exciting business opportunities for the vendors. Recent developments in the dressings with micro-fibers and biosensing for smart wound dressing enable quantitative, real-time representation of the wound environment, including pathogen concentrations, exudate levels, and tissue regeneration are likely to influence the market significantly.
This research report includes detailed segmentation by
The growing wound management cost and the increasing population size with acute and chronic infections are increasing the demand for alginate dressings.
The antimicrobial wound dressings segment is growing due to the high prevalence of several chronic infections. The high demand for these dressings is leading to the introduction of a broad range of dressing offerings, which, in turn, are boosting the segment. Moreover, key vendors are focusing on several clinical trials to increase the efficacy of these dressings, thereby increasing market opportunities.
Wound biologics is the second largest segment of the bioactive wound care market. The segment is growing primarily due to the rising incidence of DFUs, venous ulcers, burn injuries, trauma, surgical site infections, and other accidental injuries globally. The increasing wound management cost and the increasing population size with various acute and chronic infections are increasing the demand for alginate dressings. Further, a wide range of commercially available alginate dressings is also driving the growth. Recently, several key players have offered silver-impregnated alginate dressings to treat the infections.
The phenomenal growth in surgical site infections is a key factor for the growth of the acute wound care segment
The bioactive wound care market is growing mainly on account of the rise in surgical procedures due to the growing incidence of chronic diseases. According to the WHO, approximately 234·2 million major surgical procedures are performed globally every year. The rise in surgical procedures, especially in the geriatric population, which also suffer from several acute and chronic diseases worldwide, is projected to influence the acute bioactive wound care segment. The phenomenal growth in the surgical site infections is another key factor for the growth of the segment. Furthermore, the number of burn cases is also increasing globally over the years. Therefore, the growing incidence of acute wounds and associated infections is fueling the growth of the segment.
The application of several wound care products in home healthcare settings is expected to increase steadily during the forecast period
In 2018, the hospital & specialty care clinic segment was the leading end-user segment. The bioactive wound care market shares are growing mainly due to the increasing prevalence of acute infections, the growing number of surgical procedures, the increasing awareness of advanced products, and increasing number treatments being conducted in hospitals.
The long-term care facility segment is growing at a steady pace. The rise in incidences of chronic infections is growing due to the increasing patient population with lifestyle diseases such as diabetes. The growing elderly population is also contributing to the growth of the segment.
The home healthcare segment is witnessing the fastest CAGR in all other end-user segments. This segment is expected to increase steadily during the forecast period as the cost of hospital stay has significantly increased. Many vendors are also increasingly developing bioactive wound care products with features such as portability, ease of use, and low costs. The introduction of these features is likely to increase the adoption of in home healthcare settings.
The increase in R&D for the development of innovative products will have a positive impact on the North American market
In 2018, North America was the largest region of the global bioactive wound care market. The growing population suffering from several acute and chronic infections is the primary factor for the high share. Europe is the second-largest market and the growth is on account of highly sophisticated healthcare infrastructure, the patient population with high awareness of bioactive wound care.
APAC is the fastest-growing market. The growing awareness of available treatment options and the increasing aging population are the major factors driving the growth. Favorable government initiatives and improved healthcare infrastructure are further driving the growth in the APAC region. Brazil, Mexico, and Argentina are the major revenue contributors in Latin America region. The growing incidence of several disease-related infections and the high prevalence of surgical infections are major drivers of the market.
Turkey, South Africa, Saudi Arabia, and Iran are the major revenue contributors to the MEA market. The market is growing due to the growing frequency of acute infections in the patient population with chronic diseases, high healthcare expenditure, and a large middle-class population with high spending power.
The global bioactive wound care market is highly competitive and dynamic, characterized by the presence of many global, regional, and local vendors offering a diverse range of products for treating various acute and chronic infections. Approximately more than 300 vendors are offering a wide array of products worldwide. Multiple product launches, strategic acquisitions, and diversified product portfolio fueled their growth in recent years. New product launches and strategic acquisitions, collaborations, will be crucial for companies to maintain revenue growth in the coming years.
Segmentation by Products
By Wound Type
By End-users
By Geography
Frequently Asked Questions
What is the bioactive wound care market size and growth rate during the forecast period?
The global bioactive wound care market size to cross USD 5.5 billion by 2024, growing at a CAGR of over 6% during the forecast period
What are the factors influencing the growth of bioactive wound care market share?
The bioactive wound care market is growing mainly on account of the rise in surgical procedures due to the growing incidence of chronic diseases. The growing incidence of chronic infection, including pressure ulcers, diabetic foot ulcers, venous ulcers as well as injuries related to burn, trauma, accidents, and surgery, is likely to increase the demand for innovative products.
Which is the fastest growing end-user segment in the bioactive wound care market?
The home healthcare segment is witnessing the fastest CAGR in all other end-user segments. This segment is expected to increase steadily during the forecast period as the cost of hospital stay has significantly increased.
Who are the leading vendors in the market, and what are their market shares?
3M, Acelity, ConvaTec, Mölnlycke Health Care, PAUL HARTMANN, and Smith & Nephew Acelity are the leading vendors in the market.
The global bioactive wound care market is growing at a CAGR of over 6% during the forecast period 2018–2024.
The following factors are likely to contribute to the growth of the market during the forecast period:
Base Year: 2018
Forecast Year: 2019–2024
The study considers the present scenario of the bioactive wound care market and its market dynamics for the period 2018−2024. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply aspect of the market. The report profiles and examines leading companies and other prominent companies operating in the market.
Key Vendors
Prominent Vendors
Market Segmentation by Products
Market Segmentation by Wound Type
Market Segmentation by End-users
Market Segmentation by Geography
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope of the study
4.4 Market Segments
4.4.1 Market Segmentation by Products
4.4.1 Market Segmentation by Wound Type
4.4.2 Market Segmentation by End-user Type
4.4.3 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at A Glance
7 Introduction
7.1 Bioactive Wound Care: Overview
7.1.1 Background
7.1.2 Bioactive Wound Care for Acute and Chronic Wounds
7.1.3 Bioactive Wound Care: Market Snapshot
8 Market Dynamics
8.1 Market Growth Enablers
8.1.1 Increasing Incidences of Acute and Chronic Wounds
8.1.2 Growing Preference for Tissue-Engineered Skin Substitutes and Growth Factors
8.1.3 High Demand for Medicated Dressing Products
8.2 Market Growth Restraints
8.2.1 High Cost of Bioactive Wound Care Products
8.2.2 Greater Availability of Substitutes for Bioactive Wound Care Products
8.2.3 Shortage of Adequate Resources for Bioactive Wound Care
8.3 Market Opportunities and Trends
8.3.1 Emergence of Stem Cell Therapy
8.3.2 Advent of Smart Bioactive Dressings
8.3.3 Growing Preference for Combination Dressings
9 Global Bioactive Wound Care Market
9.1 Market Overview
9.2 Market Size & Forecast
9.3 Five Forces Analysis
9.3.1 Threat of New Entrants
9.3.2 Bargaining Power of Suppliers
9.3.3 Bargaining Power of Buyers
9.3.4 Threat of Substitutes
9.3.5 Competitive Rivalry
10 Bioactive Wound Care Market by Product Type
10.1 Market Snapshot & Growth Engine
10.2 Market Overview
10.3 Antimicrobial Dressings
10.3.1 Market Overview
10.3.2 Market Size & Forecast
10.3.3 Antimicrobial Dressings: Segmentation by Geography
10.4 Wound Care Biologics
10.4.1 Market Overview
10.4.2 Market Size & Forecast
10.4.3 Wound Care Biologics: Segmentation by Geography
10.5 Hydrocolloid Dressings
10.5.1 Market Overview
10.5.2 Market Size & Forecast
10.5.3 Hydrocolloid Dressings: Segmentation by Geography
10.6 Alginate Dressings
10.6.1 Market Overview
10.6.2 Market Size & Forecast
10.6.3 Alginate Dressings: Segmentation by Geography
10.7 Collagen Dressings
10.7.1 Market Overview
10.7.2 Market Size & Forecast
10.7.3 Collagen Dressings: Segmentation by Geography
11 Bioactive Wound Care Market by Wound Type
11.1 Market Snapshot & Growth Engine
11.2 Market Overview
11.3 Acute Wounds
11.3.1 Market Overview
11.3.2 Market Size & Forecast
11.4 Chronic Wounds
11.4.1 Market Overview
11.4.2 Market Size & Forecast
12 Bioactive Wound Care Market by End Users
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Hospitals & Specialty Wound Care Clinics
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.4 Long-term Care Facilities
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.5 Home Healthcare
12.5.1 Market Overview
12.5.2 Market Size & Forecast
12.6 Others
12.6.1 Market Overview
12.6.2 Market Size & Forecast
13 Bioactive Wound Care Market by Geography
13.1 Market Snapshot & Growth Engine
13.2 Overview
14 North America
14.1 Market Overview
14.2 Market Size & Forecast
14.3 Segmentation by Product Type
14.4 Key Countries
14.4.1 US: Market Size & Forecast
14.4.2 Canada: Market Size & Forecast
15 Europe
15.1 Market Overview
15.2 Market Size & Forecast
15.3 Segmentation by Product Type
15.4 Key Countries
15.4.1 Germany: Market Size & Forecast
15.4.2 France: Market Size & Forecast
15.4.3 UK: Market Size & Forecast
15.4.4 Spain: Market Size & Forecast
15.4.5 Italy: Market Size & Forecast
16 APAC
16.1 Market Overview
16.2 Market Size & Forecast
16.3 Segmentation by Product Type
16.4 Key Countries
16.4.1 China: Market Size & Forecast
16.4.2 Japan: Market Size & Forecast
16.4.3 India: Market Size & Forecast
16.4.4 South Korea: Market Size & Forecast
16.4.5 Australia: Market Size & Forecast
17 Latin America
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Segmentation by Product Type
17.4 Key Countries
17.4.1 Brazil: Market Size & Forecast
17.4.2 Mexico: Market Size & Forecast
17.4.3 Argentina: Market Size & Forecast
18 Middle-East & Africa
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Segmentation by Product Type
18.4 Key Countries
18.4.1 Turkey: Market Size & Forecast
18.4.2 South Africa: Market Size & Forecast
18.4.3 Saudi Arabia: Market Size & Forecast
18.4.4 Iran: Market Size & Forecast
19 Competitive Landscape
19.1 Competition Overview
19.2 Market Share Analysis
20 Key Company Profiles
20.1 Smith & Nephew
20.1.1 Business Overview
20.1.2 Major Product Offerings
20.1.3 Smith & Nephew in Global Bioactive Wound Care Market
20.1.4 Key Strengths
20.1.5 Key Strategies
20.1.6 Key Opportunities
20.2 Mölnlycke Health Care
20.2.1 Business Overview
20.2.2 Major Product Offerings
20.2.3 Mölnlycke Health Care in Global Bioactive Wound Care Market
20.2.4 Key Strengths
20.2.5 Key Strategies
20.2.6 Key Opportunities
20.3 Acelity
20.3.1 Business Overview
20.3.2 Major Product Offerings
20.3.3 Acelity in Global Bioactive Wound Care Market
20.3.4 Key Strengths
20.3.5 Key Strategies
20.3.6 Key Opportunities
20.4 ConvaTec
20.4.1 Business Overview
20.4.2 Major Product Offerings
20.4.3 ConvaTec in Global Bioactive Wound Care Market
20.4.4 Key Strengths
20.4.5 Key Strategies
20.4.6 Key Opportunities
20.5 3M
20.5.1 Business Overview
20.5.2 Major Product Offerings
20.5.3 3M in Global Bioactive Wound Care Market
20.5.4 Key Strengths
20.5.5 Key Strategies
20.5.6 Key Opportunities
20.6 PAUL HARTMANN
20.6.1 Business Overview
20.6.2 Major Product Offerings
20.6.3 PAUL HARTMANN in Global Bioactive Wound Care Market
20.6.4 Key Strengths
20.6.5 Key Strategies
20.6.6 Key Opportunities
21 Other Prominent Vendors
21.1 Advanced Medical Solutions Group
21.1.1 Business Overview
21.1.2 Major Product Offerings
21.2 Advancis Medical
21.2.1 Business Overview
21.2.2 Major Product Offerings
21.3 Aedicell
21.3.1 Business Overview
21.3.2 Major Product Offerings
21.4 AMERX Health Care
21.4.1 Business Overview
21.4.2 Major Product Offerings
21.5 Aspen Surgical
21.5.1 Business Overview
21.5.2 Major Product Offerings
21.6 Axio Biosolutions
21.6.1 Business Overview
21.6.2 Major Product Offerings
21.7 B. Braun Melsungen
21.7.1 Business Overview
21.7.2 Major Product Offerings
21.8 BD
21.8.1 Business Overview
21.8.2 Major Product Offerings
21.9 BSN medical
21.9.1 Business Overview
21.9.2 Major Product Offerings
21.10 BTI Biotechnology Institute
21.10.1 Business Overview
21.10.2 Major Product Offerings
21.11 Cardinal Health
21.11.1 Business Overview
21.11.2 Major Product Offerings
21.12 CGbio
21.12.1 Business Overview
21.12.2 Major Product Offerings
21.13 Covalon Technologies
21.13.1 Business Overview
21.13.2 Major Product Offerings
21.14 DermaRite Industries
21.14.1 Business Overview
21.14.2 Major Product Offerings
21.15 DeRoyal Industries
21.15.1 Business Overview
21.15.2 Major Product Offerings
21.16 Ethicon
21.16.1 Business Overview
21.16.2 Major Product Offerings
21.17 Hollister
21.17.1 Business Overview
21.17.2 Major Product Offerings
21.18 Intergra LifeSciences
21.18.1 Business Overview
21.18.2 Major Product Offerings
21.19 Kaken Pharmaceutical
21.19.1 Business Overview
21.19.2 Major Product Offerings
21.2 Lohmann & Rauscher (L&R)
21.20.1 Business Overview
21.20.2 Major Product Offerings
21.21 Medline Industries
21.21.1 Business Overview
21.21.2 Major Product Offerings
21.22 MiMedx
21.22.1 Business Overview
21.22.2 Major Product Offerings
21.23 MPM Medical
21.23.1 Business Overview
21.23.2 Major Product Offerings
21.24 MTF Biologics
21.24.1 Business Overview
21.24.2 Major Product Offerings
21.25 Organogenesis
21.25.1 Business Overview
21.25.2 Major Product Offerings
21.26 SK Bioland
21.26.1 Business Overview
21.26.2 Major Product Offerings
21.27 Sutherland Medical
21.27.1 Business Overview
21.27.2 Major Product Offerings
21.28 TRIAGE MEDITECH
21.28.1 Business Overview
21.28.2 Major Product Offerings
21.29 URGO Group
21.29.1 Business Overview
21.29.2 Major Product Offerings
21.3 Vericel
21.30.1 Business Overview
21.30.2 Major Product Offerings
22 Report Summary
22.1 Key Takeaways
22.2 Strategic Recommendations
22.3 Quantitative Summary
22.3.1 By Product Type
22.3.2 By Wound Type
22.3.3 By End-users
22.3.4 By Geography
22.3.5 Antimicrobial Dressings Market by Geography
22.3.6 Wound Care Biologics Market by Geography
22.3.7 Hydrocolloid Dressings Market by Geography
22.3.8 Alginate Dressings Market by Geography
22.3.9 Collagen Dressings Market by Geography
22.3.10 North America: Segmentation by Product Type
22.3.11 Europe: Segmentation by Product Type
22.3.12 APAC: Segmentation by Product Type
22.3.13 Latin America: Segmentation by Product Type
22.3.14 MEA: Segmentation by Product Type
23 Appendix
23.1 Abbreviations
List of Exhibits
Exhibit 1 Segmentation of Global Bioactive Wound Care Market
Exhibit 2 Market Size Calculation Approach 2018
Exhibit 3 Major Market Dynamics in Bioactive Wound Care Market
Exhibit 4 Impact of Increasing Incidences of Acute and Chronic Wounds
Exhibit 5 Prevalence of MCCs in Selected Regions (%)
Exhibit 6 Impact of Growing Preference for Tissue-Engineered Skin Substitutes and Growth Factors
Exhibit 7 Key Advantages of Growth Factor Therapy
Exhibit 8 Impact of High Demand for Medicated Dressing Products
Exhibit 9 Key Benefits of Antimicrobial Dressings
Exhibit 10 Impact of High Cost of Bioactive Wound Care Products
Exhibit 11 Impact of Greater Availability of Substitutes
Exhibit 12 Impact of Shortage of Adequate Resources
Exhibit 13 Impact of Emergence of Stem Cell Therapy
Exhibit 14 Impact of Advent of Smart Bioactive Wound Dressings
Exhibit 15 Impact of Growing Preference for Combination Dressings
Exhibit 16 Global Bioactive Wound Care Market: Overview
Exhibit 17 Global Bioactive Wound Care Market 2018−2024 ($ million)
Exhibit 18 Market by Geography 2018 & 2024 (%)
Exhibit 19 Market by Product Type 2018 & 2024 (%)
Exhibit 20 Market by Wound Type 2018 & 2024 (%)
Exhibit 21 Market by End-users 2018 & 2024 (%)
Exhibit 22 Five Force Analysis 2018
Exhibit 23 Incremental Growth by Product Type 2018-2024
Exhibit 24 Global Bioactive Wound Care Market by Product Type
Exhibit 25 Market by Product: Incremental Growth
Exhibit 26 Market by Product: Absolute Growth
Exhibit 27 Market by Product 2018 & 2024 (%)
Exhibit 28 Market by Product Type 2018−2024 ($ million)
Exhibit 29 Market by Product 2018−2024 (%)
Exhibit 30 Global Antimicrobial Dressings Market 2018−2024 ($ million)
Exhibit 31 Market: Segmentation by Geography 2018 & 2024 (%)
Exhibit 32 Market: Segmentation by Geography 2018−2024 ($ million)
Exhibit 33 Market: Segmentation by Geography 2018−2024 (%)
Exhibit 34 Key Advantages of Growth Factor Therapy
Exhibit 35 Global Wound Care Biologics Market 2018−2024 ($ million)
Exhibit 36 Market: Segmentation by Geography 2018 & 2024 (% share)
Exhibit 37 Market Segmentation by Geography 2018−2024 ($ million)
Exhibit 38 Market Segmentation by Geography 2018−2024 (% share)
Exhibit 39 Global Hydrocolloid Dressings Market 2018−2024 ($ million)
Exhibit 40 Market Segmentation by Geography 2018 & 2024 (%)
Exhibit 41 Market: Segmentation by Geography 2018−2024 ($ million)
Exhibit 42 Market Segmentation by Geography 2018−2024 (%)
Exhibit 43 Global Alginate Dressings Market 2018−2024 ($ million)
Exhibit 44 Market: Segmentation by Geography 2018 & 2024 (%)
Exhibit 45 Market: Segmentation by Geography 2018−2024 ($ million)
Exhibit 46 Market: Segmentation by Geography 2018−2024 (%)
Exhibit 47 Global Collagen Dressings Market Size 2018−2024 ($ million)
Exhibit 48 Market: Segmentation by Geography 2018 & 2024 (% share)
Exhibit 49 Market: Segmentation by Geography 2018 & 2024 ($ million)
Exhibit 50 Market: Segmentation by Geography 2018 & 2024 (%)
Exhibit 51 Incremental Growth by Wound Type
Exhibit 52 Global Bioactive Wound Care Market by Wound Type
Exhibit 53 Market by Wound Type: Incremental Growth
Exhibit 54 Market by Wound Type: Absolute Growth
Exhibit 55 Market by Wound Type 2018 & 2024 (%)
Exhibit 56 Market by Wound Type 2018−2024 ($ million)
Exhibit 57 Market by Wound Type 2018−2024 (%)
Exhibit 58 Global Acute Wounds 2018 (% share revenue)
Exhibit 59 Global Bioactive Acute Wound Care Market 2018−2024 ($ million)
Exhibit 60 Revenue Share of Various Chronic Wounds 2018(%)
Exhibit 61 Global Bioactive Chronic Wounds Market 2018−2024 ($ million)
Exhibit 62 Incremental Growth by End-users 2018-2024
Exhibit 63 Global Bioactive Wound Care Market by End Users
Exhibit 64 Market by End-users: Incremental Growth
Exhibit 65 Market by End-users: Absolute Growth
Exhibit 66 Market by End-users 2018 & 2024 (%)
Exhibit 67 Market by End-users 2018−2024 ($ million)
Exhibit 68 Market by End-users 2018−2024 (%)
Exhibit 69 Market by Hospitals and Specialty Wound Care Clinics 2018−2024 ($ million)
Exhibit 70 Market by Long-term Care Facilities ($ million)
Exhibit 71 Market by Home Healthcare 2018−2024 ($ million)
Exhibit 72 Market by Other End-users 2018−2024 ($ million)
Exhibit 73 Incremental Growth by Geography 2018-2024
Exhibit 74 Global Bioactive Wound Care Market by Geography
Exhibit 75 Market by Geography: Absolute Growth
Exhibit 76 Market by Geography: Incremental Growth
Exhibit 77 Market by Geography 2018 & 2024 (%)
Exhibit 78 Market by Geography 2018−2024 ($ million)
Exhibit 79 Market by Geography 2018−2024 (%)
Exhibit 80 Market by Geography: Key Countries ($ million)
Exhibit 81 Bioactive Wound Care Market in North America: Key Countries
Exhibit 82 Market in North America 2018−2024 ($ million)
Exhibit 83 Market in North America by Product Type 2018 & 2024 (% share)
Exhibit 84 Market in North America by Product 2018−2024 ($ million)
Exhibit 85 Market in North America by Product 2018−2024 (%)
Exhibit 86 Incremental Growth in North America 2018-2024
Exhibit 87 Market in US 2018−2024 ($ million)
Exhibit 88 Market in Canada 2018−2024 ($ million)
Exhibit 89 Bioactive Wound Care Market in Europe
Exhibit 90 Diabetes Prevalence Rate among Women in Europe by Age Group 2017 (% share)
Exhibit 91 Diabetes Prevalence Rate among Men in Europe by Age Group 2017 (% share)
Exhibit 92 Bioactive Wound Care Market in Europe 2018–2024 ($ million)
Exhibit 93 Market in Europe by Product Type 2018 & 2024 (% share)
Exhibit 94 Market in Europe by Product Type 2018− 2024 ($ million)
Exhibit 95 Market in Europe by Product Type 2018−2024 (% share)
Exhibit 96 Incremental Growth in Europe 2018−2024
Exhibit 97 Market in Germany 2018–2024 ($ million)
Exhibit 98 Prevalence of Leg Ulcers in Various Age Group in France (% share)
Exhibit 99 Market in France 2018–2024 ($ million)
Exhibit 100 Market in UK 2018–2024 ($ million)
Exhibit 101 Prevalence of Diabetes in Spain 2017 (%)
Exhibit 102 Market in Spain 2018–2024 ($ million)
Exhibit 103 Market in Italy 2018–2024 ($ million)
Exhibit 104 Bioactive Wound Care Market in APAC – Key Countries
Exhibit 105 Market in APAC 2018−2024 ($ million)
Exhibit 106 Market in APAC by Product Type 2018 & 2024 (%)
Exhibit 107 Market in APAC by Product Type 2018−2024 ($ million)
Exhibit 108 Market in APAC by Product Type 2018−2024 (% share)
Exhibit 109 Incremental Growth in APAC
Exhibit 110 Prevalence of Diabetes in Adults in China (% share) 2017
Exhibit 111 Market in China 2018–2024 ($ million)
Exhibit 112 Incidence Rates of SSI in Japan 2016 (% share)
Exhibit 113 Market in Japan 2018–2024 ($ million)
Exhibit 114 Market in India 2018–2024 ($ million)
Exhibit 115 Market in South Korea 2018–2024 ($ million)
Exhibit 116 Market in Australia 2018–2024 ($ million)
Exhibit 117 Bioactive Wound Care Market in Latin America: Key Countries
Exhibit 118 Market in Latin America 2018−2024 ($ million)
Exhibit 119 Market in Latin America by Product 2018 & 2024 (% share)
Exhibit 120 Market in Latin America by Product Type 2018− 2024 ($ million)
Exhibit 121 Market in Latin America by Product Type 2018−2024 (% share)
Exhibit 122 Incremental Growth in Latin America
Exhibit 123 Market in Brazil 2018−2024 ($ million)
Exhibit 124 Market in Mexico 2018−2024 ($ million)
Exhibit 125 Market in Argentina 2018−2024 ($ million)
Exhibit 126 Bioactive Wound Care Market in MEA – Key Countries
Exhibit 127 Diabetes Prevalence Rate in Women in MEA by Age Group 2017 (% share)
Exhibit 128 Diabetes Prevalence Rate in Men in MEA by Age Group 2017 (% share)
Exhibit 129 Bioactive Wound Care Market in MEA 2018−2024 ($ million)
Exhibit 130 Market in MEA by Product Type 2018 & 2024 (%)
Exhibit 131 Market in MEA by Product Type 2018−2024 ($ million)
Exhibit 132 MEA Bioactive Wound Care Market Segmentation by Product Type 2018−2024 (%)
Exhibit 133 Incremental Growth in MEA
Exhibit 134 Market in Turkey 2018−2024 ($ million)
Exhibit 135 Market in South Africa 2018−2024 ($ million)
Exhibit 136 Market in Saudi Arabia 2018−2024 ($ million)
Exhibit 137 Market in Iran 2018−2024 ($ million)
Exhibit 138 Market: Vendors Market Share by Tier 2018 (%)
Exhibit 139 Smith & Nephew: R&D Expenditure 2016−2018 ($ million)
Exhibit 140 Smith & Nephew: Revenue by Product Category 2017−2018 ($ million)
Exhibit 141 Smith & Nephew: Revenue Based on Geographic Segments (%)
Exhibit 142 ConvaTec: R&D Expenditure 2016-2018 ($ million)
Exhibit 143 ConvaTec: Revenue by Franchise 2017-2018 ($ million)
Exhibit 144 ConvaTec: Revenue by Geography (%)
Exhibit 145 3M: Revenue by Geography (% share)
List of Tables
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2018
Table 3 Major Players Offering Wound Biologics
Table 4 Companies Offering Antimicrobial Dressings
Table 5 Key Alternative Bioactive Wound Care Products
Table 6 Key Advantages of Few Collagen-Based Combination Dressings
Table 7 Significant Players Offering Combination Dressings
Table 8 Key Commercially Available Antimicrobial Dressings
Table 9 Key Commercially Available Wound Biologics Products
Table 10 Significant Commercially Available Hydrocolloid Dressings
Table 11 Key Commercially Available Alginate Dressings
Table 12 Key Commercially Available Collagen Dressings
Table 13 Prevalence of Several Acute and Chronic Wounds in Germany (% share)
Table 14 Smith & Nephew: Key Product Offerings
Table 15 Mölnlycke Health Care: Key Product Offerings
Table 16 Acelity: Key Product Offerings
Table 17 ConvaTec: Key Product Offerings
Table 18 3M: Key Product Offerings
Table 19 PAUL HARTMANN: Key Product Offerings
Table 20 Advanced Medical Solutions Group: Key Product Offerings
Table 21 Advancis Medical: Key Product Offerings
Table 22 Aedicell: Key Product Offerings
Table 23 AMERX Health Care: Key Product Offerings
Table 24 Aspen Surgical: Key Product Offerings
Table 25 Axio Biosolutions: Key Product Offerings
Table 26 B. Braun Melsungen: Key Product Offerings
Table 27 BD: Key Product Offerings
Table 28 BSN medical: Key Product Offerings
Table 29 BTI Biotechnology Institute: Key Product Offerings
Table 30 Cardinal Health: Key Product Offerings
Table 31 CGbio: Key Product Offerings
Table 32 Covalon Technologies: Key Product Offerings
Table 33 DermaRite Industries: Key Product Offerings
Table 34 DeRoyal Industries: Key Product Offerings
Table 35 Ethicon: Key Product Offerings
Table 36 Hollister: Key Product Offerings
Table 37 Integra LifeSciences: Key Product Offerings
Table 38 Kaken Pharmaceutical: Key Product Offerings
Table 39 LOHMANN & RAUSCHER (L&R): Key Product Offerings
Table 40 Medline Industries: Key Product Offerings
Table 41 MiMedx: Key Product Offerings
Table 42 MPM Medical: Key Product Offerings
Table 43 MTF Biologics: Key Product Offerings
Table 44 Organogenesis: Key Product Offerings
Table 45 SK Bioland: Key Product Offerings
Table 46 Sutherland Medical: Key Product Offerings
Table 47 TRIAGE MEDITECH: Key Product Offerings
Table 48 URGO Group: Key Product Offerings
Table 49 Vericel: Key Product Offerings
Table 50 Global Bioactive Wound Care Market by Products ($ million)
Table 51 Market by Products (%)
Table 52 Global Bioactive Wound Care Market by Wound Type ($ million)
Table 53 Market by Wound Type (%)
Table 54 Global Bioactive Wound Care Market by End-users ($ million)
Table 55 Market by End-users (%)
Table 56 Global Bioactive Wound Care Market by Geography ($ million)
Table 57 Market by Geography (%)
Table 58 Global Antimicrobial Dressings Market by Geography ($ million)
Table 59 Market by Geography ($ million) (%)
Table 60 Global Wound Care Biologics Market by Geography ($ million)
Table 61 Market by Geography ($ million) (%)
Table 62 Global Hydrocolloid Dressings Market by Geography ($ million)
Table 63 Market by Geography ($ million) (%)
Table 64 Global Alginate Dressings Market by Geography ($ million)
Table 65 Market by Geography ($ million) (%)
Table 66 Global Collagen Dressings Market by Geography ($ million)
Table 67 Market by Geography ($ million) (%)
Table 68 Bioactive Wound Care Market in North America by Product Type ($ million)
Table 69 Market in North America by Product Type (%)
Table 70 Bioactive Wound Care Market in Europe by Product Type ($ million)
Table 71 Market in Europe by Product Type (%)
Table 72 Bioactive Wound Care Market in APAC by Product Type ($ million)
Table 73 Market in APAC by Product Type (%)
Table 74 Bioactive Wound Care Market in Latin America by Product Type ($ million)
Table 75 Market in Latin America by Product Type (%)
Table 76 Bioactive Wound Care Market in MEA by Product Type ($ million)
Table 77 Market in MEA by Product Type (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
